Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-17

FDA Approved: CHLORZOXAZONE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Chlorzoxazone submitted by Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorzoxazone (Chlorzoxazone)

Snippet

SUPPL AP for CHLORZOXAZONE (CHLORZOXAZONE)